Lv21
122 积分 2024-01-19 加入
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes
2小时前
待确认
Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response
3个月前
已完结
Cancer micrometastases
3个月前
已完结
Molecular Biology of Biotin Attachment to Proteins
5个月前
已完结
Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium
6个月前
已完结
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
6个月前
已完结
A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present
7个月前
已完结
Patent landscape of small molecule inhibitors of METTL3 (2020-present)
8个月前
已完结
The BRUTUS iron sensor and E3 ligase facilitates soybean root nodulation by monoubiquitination of NSP1
9个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
9个月前
已完结
皖公网安备34019202002308
